<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813759</url>
  </required_header>
  <id_info>
    <org_study_id>17/2015</org_study_id>
    <nct_id>NCT02813759</nct_id>
  </id_info>
  <brief_title>Sucralose in Subjects With Diabetes Mellitus Insulin Requesting</brief_title>
  <acronym>SDMIR</acronym>
  <official_title>Effect of a Sucralose Preload on Postprandial Metabolic Parameters and Satiety in Subjects With Type 2 Diabetes Mellitus Under Intensive Insulin Therapy - Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Valparaiso</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidad de Valparaiso</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the acute effect of a preload of sucralose in presence of carbohydrate (HC)
      available on the glycemic response, postprandial C peptide and satiety in patients with type
      2 diabetes mellitus (DM2) in intensive insulin therapy (IIT).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycemia</measure>
    <time_frame>up to 120 minutes</time_frame>
    <description>Glycemia (mg/dL) to -15, 30, 60 and 120 minutes, with respect to breakfast intake.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C peptide</measure>
    <time_frame>up to 60 minutes</time_frame>
    <description>C-peptide at -15 and 60 minutes with respect to breakfast intake</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satiety</measure>
    <time_frame>up to 120 minutes</time_frame>
    <description>Visual Analog Scale (VAS) was applied immediate and tardy postprandial (two hours after eating breakfast).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>Sucralose</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>14 mg sucralose (Zero K sucralose powder, IANSAÂ®) an 200 mL of water</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Water</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>200 mL of water</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sucralose</intervention_name>
    <description>Subjects drank 200 mL of water with 14 mg sucralose, followed by a standard breakfast.</description>
    <arm_group_label>Sucralose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Subjects drank 200 mL of water alone (placebo), followed by a standard breakfast.</description>
    <arm_group_label>Water</arm_group_label>
    <other_name>Water</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Minimum period of six month intensive insulin therapy

          -  Prescription rapid insulin in the breakfast

          -  Aged 35 to 70 years

          -  BMI 25 to 39.9 kg / m2

          -  HbA1c lower than or equal to 10% (86 mmol / mol)

          -  Menopausal women under hormone replacement therapy

        Exclusion Criteria:

          -  History of intolerance artificial sweetener sucralose

          -  Pregnant women

          -  Puerperal women

          -  Subjects with neurological disease, endocrine disorder no treatment, kidney disease
             stage IV or V, cancer, liver disease, chronic obstructive pulmonary disease, HIV

          -  Subjects with history of stroke , acute myocardial infarction and gastrointestinal
             resection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 16, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>June 22, 2016</last_update_submitted>
  <last_update_submitted_qc>June 22, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Valparaiso</investigator_affiliation>
    <investigator_full_name>Claudia Vega Soto</investigator_full_name>
    <investigator_title>Nutritionist</investigator_title>
  </responsible_party>
  <keyword>GLYCEMIA</keyword>
  <keyword>SATIETY</keyword>
  <keyword>C PEPTIDE</keyword>
  <keyword>PRELOAD</keyword>
  <keyword>INSULIN</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

